XenoPort生物制药(XNPT)

0 %

简介:XenoPort, Inc.于1999年5月19日在特拉华州成立,是一家生物制药公司,专注开发和销售各种内部研发的产品替代物,主要用于治疗神经性紊乱。公司的新型产品和产品替代物是经过修改目前市场上销售药物(成为母药)的化学结构创造的前体药物,设计目的是改进口服药物(母药)在吸收、分布和新陈代谢方面的缺陷。公司销售的产品和每种替代物都是口服的,专利的或可获得专利的分子药物,解决潜在市场生未满足的需求。公司的工厂位于加利福尼亚圣克拉拉。


公司网站:
公司地址:3410 Central Expressway Santa Clara California
公司电话:1-408-6167200
今开:昨收:0
最高:最低:
涨停价:跌停价:
总市值:447590300

XenoPort生物制药的最新讨论

XenoPort生物制药的公告

公告

$XenoPort(XNPT)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0001172661-17-000523 Size: 92 KB 网页链接

公告

$XenoPort(XNPT)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-08-04 AccNo: 0001144204-16-116636 Size: 91 KB 网页链接

公告

$XenoPort(XNPT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-07-14 AccNo: 0001193125-16-647859 Size: 32 KB 网页链接

公告

$XenoPort(XNPT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-07-14 AccNo: 0001193125-16-647858 Size: 32 KB 网页链接

公告

$XenoPort(XNPT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-07-14 AccNo: 0001193125-16-647856 Size: 32 KB 网页链接

公告

$XenoPort(XNPT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-07-14 AccNo: 0001193125-16-647855 Size: 32 KB 网页链接

公告

$XenoPort(XNPT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-07-14 AccNo: 0001193125-16-647849 Size: 32 KB 网页链接

公告

$XenoPort(XNPT)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2016-07-14 AccNo: 0001193125-16-647848 Size: 32 KB 网页链接